Description

Montelukast Sodium and Levocetirizine Hydrochloride Dispersible Tablets

Composition:

Each uncoated dispersible tablet contains :

Montelukast Sodium IP

equivalent to Montelukast                                      4 mg

Levocetirizine Hydrochloride IP                            12.5 mg

INDICATION & USE

• Seasonal Allergic Rhinitis

• Skin Rashes & Extrinsic Asthma